FLUIMUCIL A 600 EFFERVESCENT TABLET 600MG (REVISED FORMULA) [SIN07474P]

Product Info

FLUIMUCIL A 600 EFFERVESCENT TABLET 600MG (REVISED FORMULA)

[SIN07474P]

INDICATIONS
Fluimucil® A Effervescent Tablets 600mg and Fluimucil® Granules 600mg are indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as:

• Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis);

• Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).

POSOLOGY
Adults and children above 6 years

• 1 tablet of Fluimucil® A Effervescent Tablet 600 mg a day.

• 1 sachet of Fluimucil® Granules 600mg a day

The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician.

MODALITY OF USE
Dissolve the tablet or the content of the sachet in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained to be drunk immediately.

CONTRAINDICATIONS

• Known hypersensitivity to acetylcysteine or to any of the excipients (please see below the section Warning and Precaution – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)

• Children under 2 years of age.

• Fluimucil® A Effervescent Tablets 600mg and Fluimucil® Granules 600mg contain aspartame, thus it is contraindicated in patients suffering from phenylketonuria.